Search results
HC Wainwright Equities Analysts Increase Earnings Estimates for Myomo, Inc. (NYSEAMERICAN:MYO)
ETF DAILY NEWS· 13 hours agoMyomo, Inc. (NYSEAMERICAN:MYO – Free Report) – HC Wainwright boosted their Q3 2024 earnings estimates for shares of Myomo in a report released on Thursday, May 9th. HC < ...
Regenxbio shares target lifted by H.C. Wainwright, cites CAMPSIITE trial By Investing.com
Investing.com· 4 hours agoOn Wednesday, H.C. Wainwright adjusted its outlook on Regenxbio Inc. (NASDAQ:RGNX) shares,...
Delcath Systems shares target raised by H.C. Wainwright on strong Q1 earnings By Investing.com
Investing.com· 4 hours agoOn Wednesday, Delcath Systems Inc. (NASDAQ:DCTH) shares, received an updated price target from H.C. ...
Fennec Pharmaceuticals shares target cut by H.C.Wainwright amid sales short fall By Investing.com
Investing.com· 4 hours agoOn Wednesday, Fennec Pharmaceuticals Inc. (NASDAQ:FENC) shares experienced a revision in its...
HC Wainwright Reiterates Buy Rating for Novavax (NASDAQ:NVAX)
ETF DAILY NEWS· 13 hours agoNovavax (NASDAQ:NVAX – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a report released on Monday, Benzinga reports. HC ...
Capricor Therapeutics (NASDAQ:CAPR) Receives Buy Rating from HC Wainwright
ETF DAILY NEWS· 11 hours agoHC Wainwright reissued their buy rating on shares of Capricor Therapeutics (NASDAQ:CAPR – Free Report) in a research note released on Tuesday, Benzinga reports. HC
FY2024 EPS Estimates for First Majestic Silver Corp. (NYSE:AG) Cut by HC Wainwright
ETF DAILY NEWS· 12 hours agoFirst Majestic Silver Corp. (NYSE:AG – Free Report) (TSE:FR) – Equities research analysts at HC Wainwright lowered their FY2024 earnings estimates for shares of First Majestic ...
Ocular Therapeutix, Inc. to Post Q2 2024 Earnings of ($0.14) Per Share, HC Wainwright Forecasts...
ETF DAILY NEWS· 14 hours agoOcular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) – Analysts at HC Wainwright lowered their Q2 2024 EPS estimates for shares of Ocular Therapeutix in a research note issued ...
H.C. Wainwright: Perpetua Resources well-funded for development, raises stock PT By Investing.com
Investing.com· 1 day agoOn Tuesday, H.C. Wainwright maintained a Buy rating on Perpetua Resources (NASDAQ:PPTA) and...
CASI Pharmaceuticals shares target cut by H.C.Waingwright on increased competition By Investing.com
Investing.com· 4 hours agoWednesday, an analyst from H.C. Wainwright adjusted the price target on shares of CASI...